Natural Resistance of Leishmania infantum to Miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil

In India, visceral leishmaniasis (VL) caused by Leishmania donovani has been successfully treated with miltefosine with a cure rate of > 90%. To assess the efficacy and safety of oral miltefosine against Brazilian VL, which is caused by Leishmania infantum, a phase II, open-label, dose-escalation...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Trop Med Hyg
Egile Nagusiak: Carnielli, Juliana B. T., Monti-Rocha, Renata, Costa, Dorcas Lamounier, Molina Sesana, Aretha, Pansini, Laura N. N., Segatto, Marcela, Mottram, Jeremy C., Costa, Carlos Henrique Nery, Carvalho, Sílvio F. G., Dietze, Reynaldo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The American Society of Tropical Medicine and Hygiene 2019
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6779219/
https://ncbi.nlm.nih.gov/pubmed/31436148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.18-0949
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak